F573 for Injection for the Treatment of Liver Injury/Failure
Status:
Not yet recruiting
Trial end date:
2026-03-31
Target enrollment:
Participant gender:
Summary
This study was a randomized, double-blind, placebo-controlled Phaseâ…¡ clinical trial .
The main objective of this study was to confirm the efficacy and safety of F573 for injection
in the treatment of liver injury/failure.